These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3145090)

  • 1. Changes in relative biological effectiveness with depth of the Clatterbridge neutron therapy beam.
    Hornsey S; Myers R; Parnell CJ; Bonnett DE; Blake SW; Bewley DK
    Br J Radiol; 1988 Nov; 61(731):1058-62. PubMed ID: 3145090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the effects of p(62)-Be and d(16)-Be neutrons in the mouse kidney.
    Joiner MC
    Radiother Oncol; 1988 Nov; 13(3):211-24. PubMed ID: 3222466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of mouse skin to irradiation with neutrons from the 62 MV cyclotron at Clatterbridge, U.K.
    Joiner MC; Field SB
    Radiother Oncol; 1988 Jun; 12(2):153-66. PubMed ID: 3406459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Build-up and depth-dose characteristics of different fast neutron beams relevant for radiotherapy.
    Mijnheer BJ
    Br J Radiol; 1978 Feb; 51(602):122-6. PubMed ID: 414808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiobiological intercomparison of two clinical neutron beams using the regeneration of mouse intestinal crypts.
    Böhm L; Gueulette J; Jones DT; Beauduin M; Vynckier S; de Roubaix S; Yudelev M; Slabbert JP; Wambersie A
    Strahlenther Onkol; 1990 Mar; 166(3):242-5. PubMed ID: 2109358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in biological effectiveness of the neutron beam at Clatterbridge (62 MeV p on Be) measured with cells in vitro.
    Bewley DK; Cullen BM; Astor M; Hall EJ; Blake SW; Bonnett DE; Zaider M
    Br J Radiol; 1989 Apr; 62(736):344-7. PubMed ID: 2713592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clatterbridge high-energy neutron facility: dosimetry intercomparisons.
    Blake SW; Bonnett DE; Shaw JE; Eenmaa J; Otte V; Awschalom M; Tatcher M; Vynckier S
    Br J Radiol; 1988 Oct; 61(730):921-7. PubMed ID: 3191317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response relationship of dicentric chromosomes in human lymphocytes obtained for the fission neutron therapy facility MEDAPP at the research reactor FRM II.
    Schmid E; Wagner FM; Romm H; Walsh L; Roos H
    Radiat Environ Biophys; 2009 Feb; 48(1):67-75. PubMed ID: 18979115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microdosimetry of a 42 MeV therapy neutron beam.
    Kliauga P; Horton J; Stafford P
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):845-8. PubMed ID: 2493437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clatterbridge high-energy neutron therapy facility: specification and performance.
    Bonnett DE; Blake SW; Shaw JE; Bewley DK
    Br J Radiol; 1988 Jan; 61(721):38-46. PubMed ID: 3126848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological intercomparisons of neutron beams used for radiotherapy generated by p(+)-->Be in hospital-based cyclotrons.
    Hall EJ; Astor M; Brenner DJ
    Br J Radiol; 1992 Jan; 65(769):66-71. PubMed ID: 1336696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clatterbridge high-energy neutron therapy facility: measurements of beam parameters for clinical use.
    Shaw JE; Bonnett DE; Blake SW
    Br J Radiol; 1988 Jan; 61(721):47-53. PubMed ID: 3126849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetry intercomparisons between fast-neutron radiotherapy facilities.
    Smith AR; Almond PR
    Med Phys; 1975; 2(4):195-200. PubMed ID: 806775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetry of clinical neutron and proton beams: an overview of recommendations.
    Vynckier S; ;
    Radiat Prot Dosimetry; 2004; 110(1-4):565-72. PubMed ID: 15353710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiobiological intercomparisons of fast neutron beams used in therapy.
    Beauduin M; Gueulette J; de Coster BM; Gregoire V; Octave-Prignot M; Vynckier S; Wambersie A
    Strahlenther Onkol; 1989 Apr; 165(4):263-7. PubMed ID: 2711330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between the biological effects of high- and low-LET radiation dose components in a mixed field exposure.
    Mason AJ; Giusti V; Green S; Munck af Rosenschöld P; Beynon TD; Hopewell JW
    Int J Radiat Biol; 2011 Dec; 87(12):1162-72. PubMed ID: 21923301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RBE of the leakage radiation from the Hiletron neutron therapy unit.
    Chen F; Hendry JH; Chu G; Greene D; Bianchi M
    Br J Radiol; 1983 Aug; 56(668):551-8. PubMed ID: 6409200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary neutron doses for several beam configurations for proton therapy.
    Shin D; Yoon M; Kwak J; Shin J; Lee SB; Park SY; Park S; Kim DY; Cho KH
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):260-5. PubMed ID: 19362245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of variation in the energy spectrum of a cyclotron-produced fast neutron beam in a phantom relevant to its application in radiotherapy.
    Bonnett DE; Parnell CJ
    Br J Radiol; 1982 Jan; 55(649):48-55. PubMed ID: 6797499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent effect of a mixed-beam regimen of fast neutrons and gamma rays on a murine fibrosarcoma.
    Ando K; Koike S; Fukuda N; Kanehira C
    Radiat Res; 1984 Apr; 98(1):96-106. PubMed ID: 6718698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.